• Skip to primary navigation
  • Skip to main content
AMRA MedicalAMRA Medical

AMRA Medical

Precision for Decision

  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Set Up
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Media
  • About Us
    • About AMRA
    • Our Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us

AMRA Medical´s new CEO is accelerating the company’s position in clinical research

August 17, 2023
  • Facebook
  • Twitter
  • LinkedIn
  • Mail

LINKÖPING, Sweden, August 17, 2023 – AMRA Medical, the global leader in body composition analysis, is pleased to announce a set of significant strategic changes aimed at accelerating growth in critical areas while solidifying our position as the gold standard for body composition analysis in clinical areas of research.

A key part of this strategic redirection involves welcoming Olof Dahlqvist Leinhard, one of AMRA’s founders and Chief Scientific Officer, as the new CEO. Olof’s deep research knowledge and innovative vision promise to accelerate AMRA into furthering key areas of research and continuing to push advancement in the field of body composition analysis.

The changes at the helm are complemented by a refocused strategic direction from AMRA’s board members. The board has reasserted their dedicated, long-term focus on neuromuscular disease (NMD), musculoskeletal (MSK), and metabolic (MET) research. This emphasis on core areas of expertise signifies AMRA’s commitment to remain at the forefront of critical research.

While AMRA is successfully offering commercial applications such as the BCP Scan, providing body composition profiling within Health & Wellness, the strategy allows for strengthening of the clinical evidence for other applications like the MAsS Scan. MAsS Scan supports clinicians in their diagnosis by providing a muscle assessment score which includes muscle volume and fat measurements. AMRA is currently conducting clinical studies using MAsS Scan in liver transplant and end-stage liver disease.

Olof Dahlqvist Leinhard, CEO of AMRA Medical commented: “Our standardized MRI body composition and muscle biomarkers help differentiate new therapies under development for metabolic disorders, and provide early proof of treatment effect in neuromuscular diseases. Ultimately, we are committed to bringing our biomarkers into clinical care where we see a great unmet need for diagnostic techniques able to provide early and precise information, guiding treatment decisions in obesity related, liver, and muscular diseases.”

A cornerstone of AMRA’s strategic plan involves the continuation of its strong partnerships with industry and academic centers, clinical services, and industry organizations. Through these collaborations, AMRA is actively fostering innovation and driving significant advancements in medical research and technology.

“AMRA remains firmly rooted in our mission to transform data into health and improve the quality of life for patients worldwide,” said Olof. “Our renewed strategy and leadership position us to execute this mission effectively. We are excited about the future.”

 

About AMRA Medical
AMRA Medical is a health informatics company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision – all from a rapid whole-body MRI scan.

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

Learn more about AMRA Medical’s MRI-based services at https://amramedical.com/solutions or connect with our team of experts for a detailed discussion at info@amramedical.com.

 

Media Contact AMRA Medical

Marie Börjesson
Senior Director Brand & Marketing
marie.borjesson@amramedical.com
+46 706-281-977

All posts
  • Facebook
  • Twitter
  • LinkedIn
  • Mail
AMRA Medical
Follow us

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • Data Privacy Policy
  • Cookie Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support

Newsletter

© 2025 AMRA Medical AB
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}